Pyridoxine supplementation for levetiracetam-related neuropsychiatric adverse events in pediatric and adolescent epilepsy: a prospective, double-blind, randomized, placebo-controlled trial
Epilepsy Behav. 2025 Sep 5;172:110691. doi: 10.1016/j.yebeh.2025.110691. Online ahead of print. ABSTRACT BACKGROUND: Levetiracetam commonly causes neuropsychiatric adverse events (NPAEs) in pediatric patients, including irritability …